ebomi
Colour theme
Sign in
Insider · CIK 0001791889

5Am Partners V, LLC

CIK 0001791889 Name as filed on the most recent filing

Filed as 5Am Partners V, LLC (19)

36 transaction lines · from 19 filings · filed 2019-10-31 to 2026-08-10 The span is the filing dates this catalog holds, not the entity's full filing history. Absence here is not evidence of absence at the SEC.

How this page attributes a trade

A line appears here when the filing that carries it names this CIK as a reporting owner, not only when the parser picked this CIK as the line's primary owner. That is why a joint filing appears on both owners' pages rather than vanishing from the second one. The catalog never merges two CIKs into one person and never splits one CIK into two: identity here is the SEC's own identifier and nothing else.

01

Issuers this insider has filed against

Ordered by last-seen filing date, newest first. Roles are as filed on the Form 4 and are not normalised.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-21 05:23 UTC.

No issuer is recorded

The catalog holds no filing linking this CIK to an issuer.

02

Transactions

Every stored Form 4 line naming this reporting owner, newest transaction date first. Each row links to the filing it came from.

0 transactions · Newest transaction date first, id breaking the tie.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-21 05:23 UTC.

Transactions filed by this insider
Direction Date Issuer Code Shares Price Value USD Filing
2026-08-07 Entrada Therapeutics, Inc.
TRDA 		S, Open-market sale 52,317 disposed 6.85 358,371.45 Form 4, filing 0001231919-26-000854
2026-08-06 Entrada Therapeutics, Inc.
TRDA 		S, Open-market sale 10,494 disposed 7.00 73,458.00 Form 4, filing 0001231919-26-000854
2026-07-31 Entrada Therapeutics, Inc.
TRDA 		S, Open-market sale 1,718 disposed 6.85 11,768.30 Form 4, filing 0001231919-26-000822
2026-07-30 Entrada Therapeutics, Inc.
TRDA 		S, Open-market sale 114,756 disposed 6.93 795,259.08 Form 4, filing 0001231919-26-000822
2025-11-14 Entrada Therapeutics, Inc.
TRDA 		S, Open-market sale 200,000 disposed 8.80 1,760,000.00 Form 4, filing 0001231919-25-000522
2025-07-09 Entrada Therapeutics, Inc.
TRDA 		S, Open-market sale 20,065 disposed 7.50 150,527.63 Form 4, filing 0001415889-25-019677
2025-07-09 Entrada Therapeutics, Inc.
TRDA 		S, Open-market sale 6,935 disposed 7.50 52,026.37 Form 4, filing 0001415889-25-019677
2025-07-01 Entrada Therapeutics, Inc.
TRDA 		S, Open-market sale 18,578 disposed 7.12 132,323.66 Form 4, filing 0001415889-25-018822
2025-07-01 Entrada Therapeutics, Inc.
TRDA 		S, Open-market sale 6,422 disposed 7.12 45,741.34 Form 4, filing 0001415889-25-018822
2025-06-30 Entrada Therapeutics, Inc.
TRDA 		S, Open-market sale 18,578 disposed 6.81 126,566.34 Form 4, filing 0001415889-25-018822
2025-06-30 Entrada Therapeutics, Inc.
TRDA 		S, Open-market sale 6,422 disposed 6.81 43,751.16 Form 4, filing 0001415889-25-018822
2025-06-27 Entrada Therapeutics, Inc.
TRDA 		S, Open-market sale 55,735 disposed 6.91 385,128.85 Form 4, filing 0001415889-25-018822
2025-06-27 Entrada Therapeutics, Inc.
TRDA 		S, Open-market sale 19,265 disposed 6.91 133,121.15 Form 4, filing 0001415889-25-018822
2023-03-07 Rallybio Corp
RLYB 		S, Open-market sale 100,000 disposed 8.20 820,000.00 Form 4, filing 0001209191-23-017533
2022-06-03 Rallybio Corp
RLYB 		S, Open-market sale 99,671 disposed 12.50 1,245,887.50 Form 4, filing 0001209191-22-034858
2022-06-03 Rallybio Corp
RLYB 		S, Open-market sale 50,329 disposed 12.50 629,112.50 Form 4, filing 0001209191-22-034858
2022-05-23 Rallybio Corp
RLYB 		S, Open-market sale 66,447 disposed 13.00 863,811.00 Form 4, filing 0001209191-22-031966
2022-05-23 Rallybio Corp
RLYB 		S, Open-market sale 33,553 disposed 13.00 436,189.00 Form 4, filing 0001209191-22-031966
2022-02-08 Rallybio Corp
RLYB 		S, Open-market sale 139,539 disposed 13.05 1,820,983.95 Form 4, filing 0001209191-22-008584
2022-02-08 Rallybio Corp
RLYB 		S, Open-market sale 70,461 disposed 13.05 919,516.05 Form 4, filing 0001209191-22-008584
2021-11-02 Entrada Therapeutics, Inc.
TRDA 		P, Open-market purchase 250,000 acquired 20.00 5,000,000.00 Form 4, filing 0001209191-21-063040
2021-11-01 Cabaletta Bio, Inc.
CABA 		S, Open-market sale 258,456 disposed 13.00 3,359,928.00 Form 4, filing 0001209191-21-062716
2021-11-01 Cabaletta Bio, Inc.
CABA 		S, Open-market sale 36,544 disposed 13.00 475,072.00 Form 4, filing 0001209191-21-062716
2021-09-07 Cabaletta Bio, Inc.
CABA 		S, Open-market sale 625,000 disposed 9.70 6,062,500.00 Form 4, filing 0001209191-21-055343
2021-08-02 Rallybio Corp
RLYB 		P, Open-market purchase 615,384 acquired 13.00 7,999,992.00 Form 4, filing 0001209191-21-049821
2021-04-27 Impel Neuropharma Inc
IMPL 		P, Open-market purchase 575,000 acquired 15.00 8,625,000.00 Form 4, filing 0001209191-21-029136
2021-01-12 Cabaletta Bio, Inc.
CABA 		S, Open-market sale 74,470 disposed 13.00 968,110.00 Form 4, filing 0001209191-21-003268
2021-01-12 Cabaletta Bio, Inc.
CABA 		S, Open-market sale 10,530 disposed 13.00 136,890.00 Form 4, filing 0001209191-21-003268
2021-01-08 Cabaletta Bio, Inc.
CABA 		S, Open-market sale 264,589 disposed 13.00 3,439,657.00 Form 4, filing 0001209191-21-003268
2021-01-08 Cabaletta Bio, Inc.
CABA 		S, Open-market sale 37,411 disposed 13.00 486,343.00 Form 4, filing 0001209191-21-003268
2020-12-29 Akouos, Inc.
AKUS 		S, Open-market sale 358,352 disposed 18.00 6,450,336.00 Form 4, filing 0001209191-20-065778
2020-12-29 Akouos, Inc.
AKUS 		S, Open-market sale 111,648 disposed 18.00 2,009,664.00 Form 4, filing 0001209191-20-065778
2020-12-10 Cabaletta Bio, Inc.
CABA 		S, Open-market sale 261,084 disposed 14.75 3,850,989.00 Form 4, filing 0001209191-20-063298
2020-12-10 Cabaletta Bio, Inc.
CABA 		S, Open-market sale 36,916 disposed 14.75 544,511.00 Form 4, filing 0001209191-20-063298
2020-06-30 Akouos, Inc.
AKUS 		P, Open-market purchase 294,117 acquired 17.00 4,999,989.00 Form 4, filing 0001209191-20-040794
2019-10-29 Cabaletta Bio, Inc.
CABA 		P, Open-market purchase 454,545 acquired 11.00 4,999,995.00 Form 4, filing 0001104659-19-058504

This column is intentionally blank

No transaction line is stored for this reporting owner, though the catalog holds filings naming them. That happens when the filings report only holdings or only positions the store does not carry, and when a parse failed; each filing page states its own parse status.

Search the catalog
Codes on this page
S, Open-market sale
Open-market sale
P, Open-market purchase
Open-market purchase

Every value is as reported on the Form 4. A price the filing did not report is marked Not reported and no value is computed from it. Codes outside the open market, drawn in grey behind a dashed rule, are compensation and administrative machinery rather than a decision to trade at the prevailing price.

What this insider's stored lines contain

No transaction line is stored for this entity, so there is nothing to break down by code. The catalog holds its filings; what it does not hold is a single reportable line from them, which is a fact about the parse and about these filings, not about the entity.

How to cite this page

ebomi catalog. 5AM Partners V, LLC, insider transactions. Retrieved 2026-08-21 from https://ebomi.com/insider/0001791889

Balogh, A. Insider trading. Scientific Data 10, 237 (2023) doi:10.1038/s41597-023-02147-6

This page as JSON The JSON twin is shaped by the same read model as this page, so the two cannot disagree. Its envelope carries the canonical URL, the retrieval time, the coverage claim, and the licence statement.